Livewire has acquired Market Index, the country’s leader in free stock market data.
Find out why.

First Impression: Healthscope (HSO) FY16 Result

Bell Potter


Divisional EBITDA: Hospitals up 8.3% to $354.9m, EBITDA margin up 50bp to 18.2% reflecting on-going progress in relation to labour, procurement and revenue initiatives; NZl Pathology up 21.8% to $50.7m, EBITDA margin down 10bp to 22.8% | Hospital expansion program on track delivering 163 additional beds and nine additional operating theatres. A further ten projects across Victoria, New South Wales, Queensland and the Northern Territory are currently under construction and are expected to deliver 762 beds and 43 operating theatres by the end of FY19 | Net operating cash flow up 7.5% to $324.4m.

1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.